Request a document copy: Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

all files (of this document) in restricted access
the file(s) you requested
Cancel